Literature DB >> 17517813

The impact of passive smoking on the development of lower respiratory tract infections in children.

Pembe Keskinoglu1, Dilek Cimrin, Gazanfer Aksakoglu.   

Abstract

Environmental tobacco smoke is an important public health problem. The objective of this study was to evaluate the effect of passive smoking on lower respiratory tract infections (LRTIs) in children aged 2-12 years. A case-control study was conducted on matched-pair design. One-hundred and fifty children with LRTIs and 150 healthy children were included in the study. Data were collected through questionnaire and urine samples for the determination of cotinine levels, and were analysed by McNemar chi-square, paired t-test and Pearson correlation tests. The prevalence of parental self-reported, indoor smoking was 71.3% in children with LRTI and 72.0% in healthy children. Employing 30 ng mg(-1), the cut-off level of urinary cotinine/creatinine as commonly accepted, 87.3% of the children with LRTIs and 84.7% of healthy children were found to be passive smokers (p = 0.61, odds ratio (OR) = 0.93; confidence interval (CI) = 0.34-2.53). If 60 ng mg(-1) of urinary cotinine/creatinine was accepted as a cut-off level, it was observed that the rates of passive smoking were 76.7% and 50.7%, respectively (p = 0.000, OR = 4.72; 95% CI = 2.62-8.52). Dose-dependent exposure to environmental tobacco smoke was found to be associated with the incidence of LRTI.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17517813     DOI: 10.1093/tropej/fmm037

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  9 in total

1.  Second-hand smoke - ignored implications.

Authors:  Zahid Naeem
Journal:  Int J Health Sci (Qassim)       Date:  2015-04

2.  Decline in early childhood respiratory tract infections in the Norwegian mother and child cohort study after introduction of pneumococcal conjugate vaccination.

Authors:  Maria C Magnus; Didrik F Vestrheim; Wenche Nystad; Siri Eldevik Håberg; Hein Stigum; Stephanie J London; Marianne A R Bergsaker; Dominique A Caugant; Ingeborg S Aaberge; Per Nafstad
Journal:  Pediatr Infect Dis J       Date:  2012-09       Impact factor: 2.129

3.  Tobacco-induced alterations to Porphyromonas gingivalis-host interactions.

Authors:  Juhi Bagaitkar; Lisa R Williams; Diane E Renaud; Manjunatha R Bemakanakere; Mike Martin; David A Scott; Donald R Demuth
Journal:  Environ Microbiol       Date:  2009-01-23       Impact factor: 5.491

4.  Household environmental tobacco smoke and risks of asthma, wheeze and bronchitic symptoms among children in Taiwan.

Authors:  Ching-Hui Tsai; Jiun-Hau Huang; Bing-Fang Hwang; Yungling L Lee
Journal:  Respir Res       Date:  2010-01-29

Review 5.  Environmental tobacco smoke (ETS) and respiratory health in children.

Authors:  Maria Cheraghi; Sundeep Salvi
Journal:  Eur J Pediatr       Date:  2009-03-20       Impact factor: 3.183

6.  Demographic and Clinical Characteristics of COVID-19 in Children and the Effect of Household Tobacco Smoke Exposure on COVID-19.

Authors:  Gülşen Akkoç; Özlem Akgün; Cevher Kızılırmak; Funda Yıldız; Hatice Nilgün Selçuk Duru; Murat Elevli
Journal:  Turk Arch Pediatr       Date:  2021-07-01

7.  Exposure to environmental tobacco smoke by healthy children aged below five (Preliminary study).

Authors:  Gözde İnci; Serpil Uğur Baysal; Ali Rıza Şişman
Journal:  Turk Pediatri Ars       Date:  2018-03-01

8.  Risk of ARI among Non-exclusively Breastfed Under-Five Passive Smoker Children: A Hospital-Based Cross-sectional Study of Nepal.

Authors:  Pushpa Thapa; Achyut Raj Pandey; Raja Ram Dhungana; Bihungum Bista; Barsha Thapa; Shiva Raj Mishra
Journal:  Front Public Health       Date:  2016-02-23

9.  Awareness of health effects of exposure to secondhand smoke from cigarettes: A cross-sectional study of never-smoked adult primary care patients in Eastern Nigeria.

Authors:  Gabriel Uche Pascal Iloh; Peace Ifeoma Collins
Journal:  Avicenna J Med       Date:  2017 Oct-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.